STUDY ON EFFECTIVENESS AND OUTCOMES OF MIFEPRISTONE AND MISOPROSTOL (MTP PILLS) IN MEDICAL TERMINATION OF PREGNANCY

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2014/07/004771

Enrollment

200

Registered

2014-07-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Willing for Medical Termination of pregancy

Interventions

Intervention1: Tab Mifepristone: Dose- 200 milligrams day 1 Approved by Drug Controller of India It is an antiprogestin, which blocks the progesterone receptors in the endometrium and decidua causing

Eligibility

Inclusion criteria

Inclusion criteria: Women with

Exclusion criteria

Exclusion criteria: • Ectopic pregnancies • Patient with Bronchial asthma • Hepatic insufficiency • Chronic failure of the adrenal glands. • Clotting factor deficiencies • Current long term therapy with corticosteroids. • Drug allergy • Pregnancy of >49 days of amenorrhea • Patientâ??s not willing to participate

Design outcomes

Primary

Measure	Time frame
Complications due to Medical termination pillsTimepoint: 15 days	—

Secondary

Measure	Time frame
Success rateTimepoint: Within 15 days	—

Countries

India

Contacts

Public ContactDr Pushpa Lokare

Private

anukizhatil@gmail.com8380080590

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026